Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19 VACCINE”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04798027
What this trial is testing

Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older

Who this might be right for
COVID-19
Sanofi Pasteur, a Sanofi Company 182
Not applicableStudy completedNCT05252442
What this trial is testing

Association of the Risk for Thrombotic Thrombocytopenia Syndrome and Exposure To COVID-19 Vaccines

Who this might be right for
Covid-19
AstraZeneca 7,641,136
Early research (Phase 1)Study completedNCT04530656
What this trial is testing

Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)

Who this might be right for
COVID-19
Jiangsu Province Centers for Disease Control and Prevention 168
Testing effectiveness (Phase 2)Study completedNCT05293223
What this trial is testing

Phase IIB Study of Recombinant Novel Coronavirus Vaccine

Who this might be right for
COVID-19 Vaccine
Fundación Huésped 88
Large-scale testing (Phase 3)UnknownNCT04530396
What this trial is testing

Clinical Trial of Efficacy, Safety, and Immunogenicity of Gam-COVID-Vac Vaccine Against COVID-19

Who this might be right for
Covid19 Prevention
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 33,758
Not applicableStudy completedNCT06731127
What this trial is testing

Vaccines in a Time of Dual Pandemic: COVID-19 Vaccine in People With HIV

Who this might be right for
HIV Infections
University of Toronto 75
Post-approval studies (Phase 4)Ended earlyNCT05037266
What this trial is testing

Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen

Who this might be right for
Healthy Volunteers
Centre Hospitalier Universitaire de Saint Etienne 27
Not applicableStudy completedNCT07166770
What this trial is testing

Community-Led COVID-19 Testing Intervention to Address Mistrust

Who this might be right for
COVID-19Trust
Old Dominion University 49
Testing effectiveness (Phase 2)UnknownNCT05238441
What this trial is testing

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01E in Population Aged ≥18 Years Previously Fully Vaccinated With mRNA COVID-19 Vaccine

Who this might be right for
COVID-19Sars-CoV-2 Infection
Sinocelltech Ltd. 360
Early research (Phase 1)Study completedNCT04336410
What this trial is testing

Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers

Who this might be right for
Coronavirus Infection
Inovio Pharmaceuticals 120
Not applicableStudy completedNCT05238428
What this trial is testing

Understanding and Overcoming the Racial/Ethnic Inequalities in COVID-19 Vaccination Acceptance

Who this might be right for
Vaccine Refusal
University of Essex 4,039
Large-scale testing (Phase 3)Study completedNCT05091307
What this trial is testing

Ad26.COV2.S and Influenza Vaccines in Healthy Adults

Who this might be right for
COVID-19 Prevention
Janssen Vaccines & Prevention B.V. 861
Testing effectiveness (Phase 2)Active Not RecruitingNCT07215520
What this trial is testing

Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults

Who this might be right for
COVID-19
CastleVax Inc. 200
Testing effectiveness (Phase 2)Study completedNCT04412538
What this trial is testing

Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

Who this might be right for
COVID-19
Institute of Medical Biology, Chinese Academy of Medical Sciences 942
Testing effectiveness (Phase 2)Study completedNCT05375838
What this trial is testing

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old

Who this might be right for
SARS-CoV-2Influenza
ModernaTX, Inc. 550
Early research (Phase 1)Study completedNCT05656508
What this trial is testing

ARVAC - A New Recombinant Coronavirus Disease 2019 (COVID-19) Vaccine

Who this might be right for
COVID-19 Vaccine
Laboratorio Pablo Cassara S.R.L. 80
Large-scale testing (Phase 3)Study completedNCT05426343
What this trial is testing

Evaluate Immunogenicity and Safety of MVC-COV1901 Vaccine Compared With AZD1222

Who this might be right for
COVID-19 Vaccine
Medigen Vaccine Biologics Corp. 200
Not applicableActive Not RecruitingNCT05449418
What this trial is testing

Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities

Who this might be right for
COVID-19
Kaiser Permanente 988
Testing effectiveness (Phase 2)Study completedNCT07134725
What this trial is testing

Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMG

Who this might be right for
COVID - 19
Federal University of Minas Gerais 432
Testing effectiveness (Phase 2)UnknownNCT04988048
What this trial is testing

Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in Argentina

Who this might be right for
COVID-19 VACCINECovid19
Ministry of Public Health, Argentina 1,760
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation